Fucheng Yin

949 total citations · 1 hit paper
33 papers, 692 citations indexed

About

Fucheng Yin is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Fucheng Yin has authored 33 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Fucheng Yin's work include Cholinesterase and Neurodegenerative Diseases (6 papers), Protein Degradation and Inhibitors (6 papers) and Catalytic C–H Functionalization Methods (5 papers). Fucheng Yin is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (6 papers), Protein Degradation and Inhibitors (6 papers) and Catalytic C–H Functionalization Methods (5 papers). Fucheng Yin collaborates with scholars based in China and South Korea. Fucheng Yin's co-authors include Xiaobing Wang, Lingyi Kong, Zhongwen Luo, Shang Li, Xingchen Liu, Lailiang Qu, Heng Luo, Dehua Lu, Xinye Chen and Peng Wan and has published in prestigious journals such as ACS Catalysis, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.

In The Last Decade

Fucheng Yin

31 papers receiving 684 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progress in approved drugs from natural product resources

2024 145 citations Zhongwen Luo, Fucheng Yin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fucheng Yin China	16	382	142	139	89	72	33	692
Yi Li Wong Malaysia	13	227 0.6×	101 0.7×	116 0.8×	108 1.2×	85 1.2×	20	582
Susana D. Lucas Portugal	18	345 0.9×	114 0.8×	273 2.0×	107 1.2×	37 0.5×	40	763
Jinhong Feng China	18	471 1.2×	107 0.8×	239 1.7×	152 1.7×	42 0.6×	52	818
Young Taek Han South Korea	16	232 0.6×	104 0.7×	315 2.3×	81 0.9×	47 0.7×	64	786
Simon Wing Fai Mok Macao	21	598 1.6×	88 0.6×	161 1.2×	205 2.3×	60 0.8×	35	1.0k
Brajendra K. Tripathi United States	14	458 1.2×	107 0.8×	324 2.3×	103 1.2×	45 0.6×	32	1.0k
Henrietta Dehmlow Switzerland	15	621 1.6×	122 0.9×	197 1.4×	121 1.4×	61 0.8×	21	969
Paweł Hikisz Poland	14	232 0.6×	79 0.6×	231 1.7×	170 1.9×	41 0.6×	28	730
Seung‐Yong Seo South Korea	19	400 1.0×	86 0.6×	221 1.6×	60 0.7×	50 0.7×	76	822
Burcu Çalışkan Türkiye	20	252 0.7×	212 1.5×	458 3.3×	76 0.9×	86 1.2×	51	883

Countries citing papers authored by Fucheng Yin

Since Specialization

Citations

This map shows the geographic impact of Fucheng Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fucheng Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fucheng Yin more than expected).

Fields of papers citing papers by Fucheng Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fucheng Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fucheng Yin. The network helps show where Fucheng Yin may publish in the future.

Co-authorship network of co-authors of Fucheng Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Fucheng Yin. A scholar is included among the top collaborators of Fucheng Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fucheng Yin. Fucheng Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shang, Xinxin Li, Zhongwen Luo, et al.. (2024). Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies. Journal of Medicinal Chemistry. 67(23). 21049–21069. 2 indexed citations

Zhang, Yonglei, Long Zheng, Liangliang Ma, et al.. (2024). Discovery of Dual CDK6/BRD4 Inhibitor Inducing Apoptosis and Increasing the Sensitivity of Ferroptosis in Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 67(23). 21186–21207. 6 indexed citations

Li, Shang, Xinxin Li, Zhongwen Luo, et al.. (2024). Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis. Journal of Medicinal Chemistry. 67(17). 15353–15372. 6 indexed citations

Zhang, Yonglei, Fucheng Yin, Zhongwen Luo, et al.. (2024). Improving tumor sensitivity by the introduction of an ester chain to triaryl derivatives targeting PD-1/PD-L1. European Journal of Medicinal Chemistry. 271. 116433–116433. 1 indexed citations

Yin, Fucheng, et al.. (2024). Stereoselective Synthesis of β, γ‐Fused Bicyclic γ‐Ureasultams via an Intramolecular Mannich and aza‐Michael Addition Cascade. Chemistry - A European Journal. 30(28). e202400438–e202400438. 2 indexed citations

Luo, Zhongwen, Shang Li, Yonglei Zhang, et al.. (2023). Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease. European Journal of Medicinal Chemistry. 256. 115415–115415. 9 indexed citations

Li, Xinxin, Cheng Wang, Shang Li, et al.. (2023). Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy. European Journal of Medicinal Chemistry. 265. 116054–116054. 11 indexed citations

Chen, Xinye, Cheng Wang, Dehua Lu, et al.. (2023). Design, synthesis and mechanism studies of dual EZH2/BRD4 inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry. 91. 117386–117386. 6 indexed citations

Wang, Cheng, Heng Luo, Xinye Chen, et al.. (2023). Discovery of dual PARP and CDK6 inhibitors for triple-negative breast cancer with wild-type BRCA. Bioorganic Chemistry. 139. 106683–106683. 11 indexed citations

10.

Zhao, Yucheng, L. Han, Libo Zhang, et al.. (2023). Two types of coumarins-specific enzymes complete the last missing steps in pyran- and furanocoumarins biosynthesis. Acta Pharmaceutica Sinica B. 14(2). 869–880. 21 indexed citations

11.

Wan, Siyuan, Xinye Chen, Fucheng Yin, et al.. (2023). Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer. European Journal of Medicinal Chemistry. 261. 115843–115843. 4 indexed citations

12.

Yin, Fucheng, Cheng Wang, Lailiang Qu, et al.. (2022). Rhodium(III)‐catalyzed Cleavage of C−C Bond and C−H Bond Cascaded by Michael Addition for the Conversion of α ‐Hydroxy Ketones to Phthalides and Isocoumarins. Asian Journal of Organic Chemistry. 11(4). 1 indexed citations

13.

Lu, Dehua, Lailiang Qu, Cheng Wang, et al.. (2022). Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy. Bioorganic Chemistry. 120. 105604–105604. 16 indexed citations

14.

Wang, Cheng, Xinye Chen, Yonglei Zhang, et al.. (2022). Discovery of Dual PARP and CDK6 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA. SSRN Electronic Journal. 1 indexed citations

15.

Wang, Cheng, Xinye Chen, Xingchen Liu, et al.. (2022). Discovery of precision targeting EZH2 degraders for triple-negative breast cancer. European Journal of Medicinal Chemistry. 238. 114462–114462. 38 indexed citations

16.

Liu, Xingchen, Cheng Wang, Shang Li, et al.. (2021). Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer. Journal of Medicinal Chemistry. 64(23). 17304–17325. 24 indexed citations

17.

Wáng, Chéng, Lailiang Qu, Shang Li, et al.. (2021). Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA. Journal of Medicinal Chemistry. 64(17). 12630–12650. 56 indexed citations

18.

Yang, Huali, Xiaobing Wang, Cheng Wang, et al.. (2020). Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer. European Journal of Medicinal Chemistry. 210. 113080–113080. 15 indexed citations

19.

Wang, Cheng, Shang Li, Jinhua Zhao, et al.. (2020). Design and SAR of Withangulatin A Analogues that Act as Covalent TrxR Inhibitors through the Michael Addition Reaction Showing Potential in Cancer Treatment. Journal of Medicinal Chemistry. 63(19). 11195–11214. 29 indexed citations

20.

Fang, Siqiang, Xiaobing Wang, Fucheng Yin, et al.. (2019). Palladium-Catalyzed meta-C–H Olefination of Arene-Tethered Diols Directed by Well-Designed Pyrimidine-Based Group. Organic Letters. 21(6). 1841–1844. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact